Claudio Brancolini

Udine, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Experimental strategies for evaluating the impact of HDACs and HDAC inhibitors on the epigenome. ChiP-seq.

Experimental strategies for evaluating the impact of HDACs and HDAC inhibitors on the epigenome. ChiP-seq.

Journal: Methods in enzymology
Published: August 20, 2026

An affordable and low-waste protocol for rapid and robust solid-phase peptide synthesis at elevated temperatures.

An affordable and low-waste protocol for rapid and robust solid-phase peptide synthesis at elevated temperatures.

Journal: Bioorganic chemistry
Published: June 07, 2026

Class IIa HDACs Are Important Signal Transducers with Unclear Enzymatic Activities.

Class IIa HDACs Are Important Signal Transducers with Unclear Enzymatic Activities.

Journal: Biomolecules
Published: July 09, 2025

Identification of a novel minor-groove DNA binder that represses mitochondrial gene expression and induces apoptosis in highly aggressive leiomyosarcoma cells.

Identification of a novel minor-groove DNA binder that represses mitochondrial gene expression and induces apoptosis in highly aggressive leiomyosarcoma cells.

Journal: Cell death discovery
Published: June 17, 2025

Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer.

Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer.

Journal: Molecular oncology
Published: May 19, 2025

ProOvErlap: Assessing feature proximity/overlap and testing statistical significance from genomic intervals.

ProOvErlap: Assessing feature proximity/overlap and testing statistical significance from genomic intervals.

Journal: The Journal of biological chemistry
Published: February 05, 2025

HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.

HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.

Journal: Cancer drug resistance (Alhambra, Calif.)
Published: August 05, 2024

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.

Journal: Pharmaceutics
Published: April 12, 2024

Dissecting transposable elements and endogenous retroviruses upregulation by HDAC inhibitors in leiomyosarcoma cells: Implications for the interferon response.

Dissecting transposable elements and endogenous retroviruses upregulation by HDAC inhibitors in leiomyosarcoma cells: Implications for the interferon response.

Journal: Genomics
Published: April 04, 2024

Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids.

Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 08, 2024

Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels.

Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels.

Journal: Life (Basel, Switzerland)
Published: December 05, 2023

Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA.

Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA.

Journal: Journal of molecular biology
Published: October 15, 2023
Showing 1-12 of 56

Last Updated: 09/26/2026